135 related articles for article (PubMed ID: 31135446)
1. The Incidence of Labelling of Non-Lung Adenocarcinomas With Antibodies Against TTF-1 and Diagnostic Implications.
Prabhakaran S; Woo WLW; Xing G; Moffat D; Hussey M; Henderson DW; Klebe S
Appl Immunohistochem Mol Morphol; 2020 Jul; 28(6):471-476. PubMed ID: 31135446
[TBL] [Abstract][Full Text] [Related]
2. An immunohistochemical comparison of two TTF-1 monoclonal antibodies in atypical squamous lesions and sarcomatoid carcinoma of the lung, and pleural malignant mesothelioma.
Klebe S; Swalling A; Jonavicius L; Henderson DW
J Clin Pathol; 2016 Feb; 69(2):136-41. PubMed ID: 26281863
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and molecular implications of aberrant thyroid transcription factor-1 expression in colorectal carcinomas: an immunohistochemical analysis of 1319 cases using three different antibody clones.
Bae JM; Kim JH; Park JH; Park HE; Cho NY; Kang GH
Histopathology; 2018 Feb; 72(3):423-432. PubMed ID: 28914964
[TBL] [Abstract][Full Text] [Related]
4. Comparison of Three Different TTF-1 Clones in Resected Primary Lung Cancer and Epithelial Pulmonary Metastases.
Vidarsdottir H; Tran L; Nodin B; Jirström K; Planck M; Mattsson JSM; Botling J; Micke P; Jönsson P; Brunnström H
Am J Clin Pathol; 2018 Oct; 150(6):533-544. PubMed ID: 30169783
[TBL] [Abstract][Full Text] [Related]
5. Variable sensitivity and specificity of TTF-1 antibodies in lung metastatic adenocarcinoma of colorectal origin.
Compérat E; Zhang F; Perrotin C; Molina T; Magdeleinat P; Marmey B; Régnard JF; Audouin J; Camilleri-Broët S
Mod Pathol; 2005 Oct; 18(10):1371-6. PubMed ID: 15861215
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Utility of Thyroid Transcription Factor-1 in Ovarian Carcinoma and Its Relationship With Clinicopathologic Prognostic Parameters.
Hakim SA; Youssef NS
Appl Immunohistochem Mol Morphol; 2017 Apr; 25(4):237-243. PubMed ID: 26657873
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of TTF-1 expression in patients with stage IV lung adenocarcinomas.
Schilsky JB; Ni A; Ahn L; Datta S; Travis WD; Kris MG; Chaft JE; Rekhtman N; Hellmann MD
Lung Cancer; 2017 Jun; 108():205-211. PubMed ID: 28625636
[TBL] [Abstract][Full Text] [Related]
8. Thyroid transcription factor-1 in primary CNS tumors.
Kristensen MH; Nielsen S; Vyberg M
Appl Immunohistochem Mol Morphol; 2011 Oct; 19(5):437-43. PubMed ID: 21325940
[TBL] [Abstract][Full Text] [Related]
9. Re-evaluating TTF-1 immunohistochemistry in diffuse gliomas: Expression is clone-dependent and associated with tumor location.
Pratt D; Afsar N; Allgauer M; Fetsch P; Palisoc M; Pittaluga S; Quezado M
Clin Neuropathol; 2017; 36(6):263-271. PubMed ID: 28933335
[TBL] [Abstract][Full Text] [Related]
10. Thyroid transcription factor-1 expression in colorectal adenocarcinomas.
Dettmer M; Kim TE; Jung CK; Jung ES; Lee KY; Kang CS
Pathol Res Pract; 2011 Nov; 207(11):686-90. PubMed ID: 22019009
[TBL] [Abstract][Full Text] [Related]
11. Aberrant TTF-1 Expression in Peripheral T-Cell Lymphomas: A Diagnostic Pitfall.
Chang ST; Chen SW; Chen BJ; Pan ST; Karube K; Chuang SS
Int J Surg Pathol; 2021 Apr; 29(2):165-168. PubMed ID: 32772757
[TBL] [Abstract][Full Text] [Related]
12. Comparison of thyroid transcription factor-1 expression by 2 monoclonal antibodies in pulmonary and nonpulmonary primary tumors.
Matoso A; Singh K; Jacob R; Greaves WO; Tavares R; Noble L; Resnick MB; Delellis RA; Wang LJ
Appl Immunohistochem Mol Morphol; 2010 Mar; 18(2):142-9. PubMed ID: 19887917
[TBL] [Abstract][Full Text] [Related]
13. TTF-1 expression in breast carcinoma: an unusual but real phenomenon.
Ni YB; Tsang JY; Shao MM; Chan SK; Tong J; To KF; Tse GM
Histopathology; 2014 Mar; 64(4):504-11. PubMed ID: 24111789
[TBL] [Abstract][Full Text] [Related]
14. Different cutoff values for thyroid transcription factor-1 antibodies in the diagnosis of lung adenocarcinoma.
Smits AJ; Vink A; Tolenaars G; Herder GJ; Kummer JA
Appl Immunohistochem Mol Morphol; 2015 Jul; 23(6):416-21. PubMed ID: 25356948
[TBL] [Abstract][Full Text] [Related]
15. [TTF-1 (8G7G3/1) positive colon adenocarcinoma: diagnostic implications].
Reis HG; Metz CH; Baba HA; Bornfeld N; Schmid KW; Metz KA
Pathologe; 2011 Jul; 32(4):349-51. PubMed ID: 21161231
[TBL] [Abstract][Full Text] [Related]
16. Expression of thyroid transcription factor-1 in colorectal carcinoma.
Xu B; Thong N; Tan D; Khoury T
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):244-9. PubMed ID: 20042854
[TBL] [Abstract][Full Text] [Related]
17. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs.
Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C
Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159
[TBL] [Abstract][Full Text] [Related]
18. Immunoreactivity for thyroid transcription factor-1 in stage I non-small cell carcinomas of the lung.
Pelosi G; Fraggetta F; Pasini F; Maisonneuve P; Sonzogni A; Iannucci A; Terzi A; Bresaola E; Valduga F; Lupo C; Viale G
Am J Surg Pathol; 2001 Mar; 25(3):363-72. PubMed ID: 11224607
[TBL] [Abstract][Full Text] [Related]
19. Significant expression of thyroid transcription factor-1 in pulmonary squamous cell carcinoma detected by SPT24 monoclonal antibody and CSA-II system.
Kashima K; Hashimoto H; Nishida H; Arakane M; Yada N; Daa T; Yokoyama S
Appl Immunohistochem Mol Morphol; 2014; 22(2):119-24. PubMed ID: 23531851
[TBL] [Abstract][Full Text] [Related]
20. Expression of CDX2 and Thyroid Transcription Factor-1 in Oropharyngeal Undifferentiated Carcinomas: A Potential Diagnostic Pitfall.
Chernock RD; Bibbey S; El-Mofty SK; Carpenter DH; Lewis JS
Appl Immunohistochem Mol Morphol; 2018 Apr; 26(4):268-273. PubMed ID: 27389559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]